Covered recipient · General Payments record
AMANDA NICOLE JIMENEZ
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2023–2024
$203.87
- Reported across 13 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $139.72 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $28.87 | 2 |
| Novo Nordisk AS | $18.46 | 1 |
| SCPHARMACEUTICALS INC. | $17.82 | 1 |
| VERTEX PHARMACEUTICALS INCORPORATED | $17.54 | 1 |
| PFIZER INC. | $16.60 | 1 |
| Janssen Pharmaceuticals, Inc | $16.08 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $13.17 | 1 |
| CVRx Inc. | $11.18 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.87 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103996945 | CMS |
| ABBVIE INC. | $15.00 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103996947 | CMS |
| CVRx, Inc. | $11.18 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132814597 | CMS |
| Janssen Pharmaceuticals, Inc | $16.08 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078176351 | CMS |
| Novartis Pharmaceuticals Corporation | $13.17 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087105214 | CMS |
| Novo Nordisk Inc | $18.46 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097432473 | CMS |
| PFIZER INC. | $16.60 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131467590 | CMS |
| SCPHARMACEUTICALS INC. | $17.82 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132313853 | CMS |
| VERTEX PHARMACEUTICALS INCORPORATED | $17.54 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105911004 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.